1-3 of 3
Francesco Fabbri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B262: Tyrosine kinase inhibitors induce rapid cellular alterations in breast cancer cells in vitro

Free
Carloni Silvia, Francesco Fabbri, Giovanni Brigliadori, Paola Ulivi, Dino Amadori, Rosella Silvestrini, Wainer Zoli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B262.
https://doi.org/10.1158/1535-7163.TARG-09-B262
Published: 10 December 2009
View articletitled, Abstract B262: Tyrosine kinase inhibitors induce rapid cellular alterations in breast cancer cells in vitro
Journal Articles

Abstract A83: Liposomal doxorubicin induces Golgi‐dependent apoptosis in hormone‐refractory prostate cancer cell lines (HRPC)

Free
Francesco Fabbri, Silvia Carloni, Giovanni Brigliadori, Paola Ulivi, Anna Tesei, Marco Montanari, Dino Amadori, Rosella Silvestrini, Wainer Zoli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A83.
https://doi.org/10.1158/1535-7163.TARG-09-A83
Published: 10 December 2009
View articletitled, Abstract A83: Liposomal doxorubicin induces Golgi‐dependent apoptosis in hormone‐refractory prostate cancer cell lines (HRPC)
Journal Articles

Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

Free
Carlo Leonetti, Marco Scarsella, Gabriella Zupi, Wainer Zoli, Dino Amadori, Laura Medri, Francesco Fabbri, Marco Rosetti, Paola Ulivi, Lorenzo Cecconetto, Manlio Bolla, Anna Tesei
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 919–926.
https://doi.org/10.1158/1535-7163.MCT-05-0536
Published: 28 April 2006
View articletitled, Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts
Open the PDF for Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts in another window